Use of ranibizumab for the treatment of subretinal neovascularization in pathologic myopia: a prospective study
Purpose: To determine the efficacy of ranibizumab as a treatment for subretinal neovascularization (SRNV) in pathologic myopia. Materials and Methods: This was an uncontrolled, prospective cohort study, involving 66 pathologic myopic eyes (65 patients) with SRNV. Patients were treated with 0.05-mL (...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
Ukrainian Society of Ophthalmologists,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |